US tariffs could slash Fisher & Paykel Healthcare’s profit by $46m, analysts warn

US tariffs could slash Fisher & Paykel Healthcare’s profit by $46m, analysts warn
Fisher & Paykel could pass on potential tariff costs to customers, but those options will be limited by its market postition, Craigs analysts say. (Image: Fisher & Paykel Healthcare)
Rebecca Stevenson
US tariffs could mean a $46 million hit to Fisher & Paykel Healthcare’s profit in a worst-case scenario, analysts say. A research note by Craigs Investment Partners considered three potential tariff scenarios from the new US government under the leadership of President Donald Trump. About 40% of New Zealand Exchange-listed (NX) Fisher & Paykel Healthcare’s sales are in the US, or about 75% of its revenue. Trump has threatened to levy tariffs against imports from countries such as Mexico, Canada and China....

More Markets

NZX down as property company gets key renewal
Markets Market Close

NZX down as property company gets key renewal

ASB Bank has extended the lease for its downtown Auckland site for another nine years.

Anna Scott joining Mercer
Markets

Anna Scott joining Mercer

Former Smart boss will replace current Mercer chief executive Martin Lewington.

Solar still on the rise, Ecotricity says
Markets

Solar still on the rise, Ecotricity says

Commercial solar generation is up almost 300%.

Expectations of rate cuts boost NZ sharemarket in light trade
Markets Market close

Expectations of rate cuts boost NZ sharemarket in light trade

There were 89 rises and 48 falls on the main board.

Jamie Gray 02 Jul 2025